Company Data
Pharvaris N.V.
Ticker
PHVS
Current Price
$28.58 -0.69%
Market Cap
$1.9B
Price Target
Refer to Report
Volume
149.2K
52wk Range
$13.44 - $29.85
Overview
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.